Vectura Group plc, a stalwart of the UK biotech sector, has agreed to be acquired by The Carlyle Group in a deal worth £958m ($1.36bn), the latest example of private equity firm's increased interest in the healthcare space.
The board at the Chippenham-based inhalation specialist which is listed on the London Stock Exchange, has recommended a £1.55 per...








